FINN Partners, a leading global integrated marketing and communications agency, has appointed Sophie Taylor-Roberts as Managing Partner and UK Health Group Lead. Taylor-Roberts will lead the FINN UK Health Group in strengthening its reputation as a leading communications partner for the biopharma, medical device and health system sectors. She succeeds Julie Adrian, who returned to her role as head of Alverium Health.
Taylor-Roberts joins FINN at a time of strong momentum for the Global Health Practice, led by Fern Lazar, Managing Partner. The practice continues to experience rapid growth across EMEA, North America, and Asia, fueled by rising demand for integrated health communications, patient-centered brand strategy, and its presence on four continents.
Health Technology Insights: Physician Disability Insurance: Set for Life Insurance Warns of Mental Health Exclusions
Taylor-Roberts has built strong partnerships with life sciences companies, ranging from biotech and medical devices to large multinational pharmaceutical firms. Her background in science, combined with her strategic communication skills, enables her to guide organizations through product launches, regulatory milestones, reputation building, and trust cultivation.
“At the heart of great health communications agencies is strategic partnership with clients, built on deep insight into, and understanding of stakeholders and audiences, sector challenges, and business opportunities. Integrated marketing communication is a powerful tool for companies striving to make a difference to health systems around the globe. I’m honored to join the FINN Global Health Practice and work alongside colleagues who are equally committed to championing health innovation,” said Sophie Taylor-Roberts, managing partner, UK Health Group Lead, FINN Partners.
Health Technology Insights: CT-155 Meets Primary Endpoint in Schizophrenia Study
With more than 20 years of experience in health communications, Taylor-Roberts has held senior positions at Good Relations, Hill+Knowlton Strategies (now Burson) and Red Consultancy. Most recently, she served as Managing Director, Healthcare UK at Hill+Knowlton Strategies, where she led the division through a substantial period of growth, delivering integrated, award-winning campaigns for clients including GSK, Haleon, Takeda and Roche. Her career has been defined by a commitment to advancing health equity, patient engagement and operational excellence.
“Sophie brings an exceptional blend of strategic insight, leadership acumen and a proven track record of client successes. Her experience in building high-performing teams and delivering breakthrough communications for health innovation clients will be a tremendous asset as we continue to expand our health capabilities across the UK and Ireland,” said Fern Lazar, Managing Partner, Global Health Practice Lead, FINN Partners.
Chantal Bowman-Boyles, Managing Partner, EMEA, adds, “Sophie’s appointment reflects our commitment to growing FINN’s presence in the region. Her commitment to our values, and ability to align client objectives with actionable strategies and bold creativity further elevates our UK Health Group and unlocks new opportunities for cross-border collaboration.”
“Sophie brings her proven combination of strategic clarity, creative courage and human-centered leadership to our growing UK Health Group and the FINN Global Health Practice,” said Gil Bashe, Chair Global Health and Purpose. “Her experience across the health industry spectrum—from pharma and biotech to healthtech to advocacy and access—equips our clients with the foresight and flexibility that health transformation need to succeed.”
Health Technology Insights: Merit Medical Launches Prelude Wave with SnapFix Technology
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
Source- PR Newswire
